Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pro Dex (PDEX) Research & Development (2016 - 2025)

Pro Dex's Research & Development history spans 13 years, with the latest figure at $734000.0 for Q4 2025.

  • For Q4 2025, Research & Development fell 22.08% year-over-year to $734000.0; the TTM value through Dec 2025 reached $3.4 million, down 0.83%, while the annual FY2025 figure was $3.6 million, 14.02% up from the prior year.
  • Research & Development for Q4 2025 was $734000.0 at Pro Dex, down from $768000.0 in the prior quarter.
  • Across five years, Research & Development topped out at $1.2 million in Q2 2021 and bottomed at $467000.0 in Q4 2022.
  • The 5-year median for Research & Development is $796500.0 (2023), against an average of $820700.0.
  • The largest annual shift saw Research & Development plummeted 40.4% in 2022 before it soared 68.74% in 2023.
  • A 5-year view of Research & Development shows it stood at $615000.0 in 2021, then dropped by 24.07% to $467000.0 in 2022, then skyrocketed by 68.74% to $788000.0 in 2023, then rose by 19.54% to $942000.0 in 2024, then decreased by 22.08% to $734000.0 in 2025.
  • Per Business Quant, the three most recent readings for PDEX's Research & Development are $734000.0 (Q4 2025), $768000.0 (Q3 2025), and $904000.0 (Q2 2025).